Home Blog Page 6

United Spirits Clarification on Information Request from Ministry of Corporate Affairs

0

United Spirits has addressed a notice received from the Ministry of Corporate Affairs (MCA) requesting information under Section 217(2) of the Companies Act, 2013. The company received the notice on November 3, 2025, and the delay in responding was due to assessing the nature of the request. United Spirits states that it has not received the MCA order referenced in the initial notice.

Information Request from MCA

United Spirits Limited is responding to a request for information from the Ministry of Corporate Affairs (MCA). The request, issued under Section 217(2) of the Companies Act, 2013, was initially communicated via email on October 31, 2025, and forwarded to the Company’s Compliance Officer on November 3, 2025.

Details of the Delay

The company acknowledges a delay in responding to the notice. This delay, according to the company’s statement, was attributable to the time required to assess the nature and scope of the information requested. The Company has stated that it has not received the MCA order referenced in the notice.

Source: BSE

Ather Energy Internet Fund III Pte. Ltd. Reduces Stake

0

Internet Fund III Pte. Ltd. has decreased its stake in Ather Energy Limited. Prior to the disposal, the fund held 5.09% of the company’s shares. Following the transaction conducted on November 6, 2025, the fund’s holding has been reduced to 0%. The shares were sold on the open market, impacting the total share and voting capital of Ather Energy.

Shareholding Adjustment

Internet Fund III Pte. Ltd. has adjusted its investment in Ather Energy Limited, according to a recent disclosure. The transaction involved the disposal of shares, leading to a change in the fund’s ownership stake.

Details of the Transaction

Before this transaction, Internet Fund III Pte. Ltd. held 193,60,832 shares, representing 5.09% of Ather Energy’s total share/voting capital (4.97% of the diluted share/voting capital). As of November 6, 2025, the fund’s holding has decreased to 0 shares, or 0.00%.

Method of Disposal

The shares were disposed of through the open market.

Impact on Share Capital

Ather Energy’s equity share capital and total voting capital before and after the sale remain at 38,03,24,241. The total diluted share/voting capital after the sale is 38,98,39,093.

Source: BSE

Hexaware Acquires 100% Stake in IAAS and IT Glitterz

0

Hexaware Technologies has completed the acquisition of 100% stake in Cybersolve (I) India Private Limited, Identity and Access Solutions LLC (IAAS), IAAS Holdings LLC, IT Glitterz LLC and Identity And Access Solutions Canada, Inc. The acquisitions will enhance Hexaware’s capabilities in digital transformation and cloud services, expanding its global reach and service offerings. This strategic move aims to strengthen Hexaware’s position in the competitive tech landscape.

Acquisition of Key Entities Finalized

Hexaware Technologies announced the completion of several strategic acquisitions dated November 6, 2025. These acquisitions are aimed at strengthening the company’s service offerings and expanding its market presence.

Details of the Acquisitions

The acquisitions include a 100% stake in:

– Cybersolve (I) India Private Limited (“Target 1”) from Identity and Access Solutions LLC (“IAAS”).

– IAAS (“Target 2”) from IAAS Holdings LLC (“IAAS Holdings”).

– IT Glitterz LLC (“Target 3”) from IT Glitterz Holdings LLC (“IT Glitterz Holdings”).

– Identity And Access Solutions Canada, Inc. (“Target 4”) from Anushree Agarwal and Neha Agarwal.

Strategic Alignment

These acquisitions are expected to be pivotal in enhancing Hexaware’s capabilities and expanding its reach within the technology sector. The execution of the share purchase agreement (“India SPA”) and securities purchase agreement (“Global SPA”) for each transaction is a move toward strengthening Hexaware’s position in the competitive tech landscape.

Source: BSE

Max Healthcare Board to Consider Financial Results on November 14, 2025

0

The Board of Directors of Max Healthcare Institute Limited is scheduled to meet on Friday, November 14, 2025, to review and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. Trading window remains closed for designated persons until 48 hours after the declaration of results.

Financial Results Announcement

Max Healthcare has announced a board meeting to be held on November 14, 2025. During this meeting, the board will consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2025.

Trading Window Closure

In line with company policy, the trading window for securities remains closed for all designated individuals and their immediate relatives. This restriction will continue until 48 hours following the declaration of the company’s financial results.

Source: BSE

Concord Biotech Board to Approve Q2 & H1 Unaudited Financial Results

0

Concord Biotech’s Board of Directors will convene on November 13, 2025, to review and approve the standalone and consolidated unaudited financial results for the second quarter (Q2: Jul-Sep) and first half (H1) of the fiscal year ended September 30, 2025. The meeting will also involve reviewing the auditors’ report and considering other business matters.

Board Meeting for Financial Results

A meeting of the Board of Directors of Concord Biotech is scheduled for November 13, 2025. The primary agenda is to consider and approve the Standalone and Consolidated Unaudited Financial Results. These results are for the second quarter (Q2: Jul-Sep) and the half-year (H1), both ending September 30, 2025.

Trading Window Closure

In line with company policy, the trading window for dealing in the company’s securities remains closed. This closure aligns with the earlier communication issued on September 25, 2025, regarding the ‘Closure of Trading Window.’ The window will remain closed until 48 hours after the declaration of the financial results for Q2 and H1 ended September 30, 2025.

Source: BSE

Maruti Suzuki ESG Rating Upgraded to BB by MSCI ESG Research

0

MSCI ESG Research LLC has upgraded Maruti Suzuki India Limited’s ESG rating to BB (in 2025) from B (in 2024). The announcement, dated November 7, 2025, confirms the upgrade, signaling improved environmental, social, and governance performance. This upgrade reflects positively on the company’s sustainability efforts.

MSCI ESG Rating Improvement

Maruti Suzuki India Limited has received an upgraded ESG rating from MSCI ESG Research LLC. The company’s ESG performance is now rated as BB, an increase from its previous rating of B. This upgrade is effective for 2025, as confirmed in the official announcement.

Details of the Upgrade

The upgrade from B (in 2024) to BB (in 2025) signifies that MSCI ESG Research recognizes improvements in Maruti Suzuki’s environmental, social, and governance practices. The company has been informed to take this change on record. This upgrade is based on the most recent evaluation by MSCI ESG Research LLC.

Source: BSE

IRCTC Supreme Court Dismisses Caterers’ Claims, Resolves Litigation

0

The Supreme Court has ruled in favor of IRCTC, dismissing all claims from caterers related to disputes over second regular meals and welcome drinks. The judgment, dated November 7, 2025, overturns previous orders and absolves IRCTC of any financial liability. This decision brings closure to the litigation, with no further financial or operational impact expected on the company.

Supreme Court Verdict

The Hon’ble Supreme Court, through its judgment on November 7, 2025, set aside the Delhi High Court’s Division Bench order dated February 10, 2025, and Single Judge orders dated August 13, 2024, along with the Arbitral Award dated April 27, 2022.

Key Court Findings

The Apex Court determined that the Arbitral Tribunal exceeded its jurisdiction by disregarding binding contractual terms and Railway Board circulars. These circulars authorized IRCTC to modify menus and tariffs unilaterally. The court observed that claims regarding reimbursement of the second regular meal and supply of welcome drinks lacked contractual and legal basis, and were contrary to governing circulars. The award was found patently illegal and against public policy.

Impact on IRCTC

The Supreme Court’s decision fully dismisses all caterers’ claims. This resolution has no financial or operational impact on IRCTC. Details of the case were disclosed in the company’s Annual Report for FY 2023-24, and last updated to exchanges on February 6, 2025.

Source: BSE

Chennai Petroleum Corporation Limited Credit Ratings Reaffirmed at CRISIL AAA/Stable

0

Chennai Petroleum Corporation Limited (CPCL) has announced that CRISIL Ratings has reaffirmed its ‘CRISIL AAA/Stable & Crisil A1+’ ratings on the company’s bank facilities and commercial paper. This decision, communicated on November 7, 2025, reflects continued confidence in CPCL’s financial stability and creditworthiness. The updated credit rating list has been posted on the company website.

Credit Ratings Maintained

CPCL’s ‘CRISIL AAA/Stable & Crisil A1+’ ratings on its financial instruments have been reaffirmed by Crisil Ratings. The reaffirmed ratings are applicable to bank facilities and commercial paper as of November 7, 2025.

Detailed Credit Rating Breakdown

Here’s a summary of the credit ratings assigned to Chennai Petroleum Corporation Limited’s debt instruments:

  • Cash Credit: CRISIL AAA/Stable for ₹3,000 Crore (State Bank of India)
  • Fund-Based Facilities: CRISIL AAA/Stable for ₹475 Crore (IndusInd Bank Limited)
  • Fund-Based Facilities: CRISIL AAA/Stable for ₹1,000 Crore (The South Indian Bank Limited)
  • Fund-Based Facilities: CRISIL AAA/Stable for ₹525 Crore (ICICI Bank Limited)
  • Fund-Based Facilities: CRISIL AAA/Stable for ₹500 Crore (HDFC Bank Limited)
  • Fund-Based Facilities: CRISIL AAA/Stable for ₹500 Crore (Punjab National Bank)
  • Fund-Based Facilities: CRISIL AAA/Stable for ₹1,000 Crore (Bank of India)
  • Fund-Based Facilities: CRISIL AAA/Stable for ₹800 Crore (Indian Bank)
  • Letter of credit & Bank Guarantee: CRISIL A1+ for ₹184 Crore (State Bank of India)
  • Proposed Long Term Bank Loan Facility: CRISIL AAA/Stable for ₹0.9 Crore
  • Commercial Papers: CRISIL & ICRA A1+ for ₹7,500 Crore
  • NCD (Withdrawn): CRISIL & ICRA AAA/Stable for ₹810 Crore; this NCD was fully redeemed/matured on 17.07.2025

Note: Full interchangeability with packing credit applies.

Source: BSE

Great Eastern Shipping K.M. Sheth Steps Down as Chairman, Bharat Sheth Appointed

0

Great Eastern Shipping has announced that K.M. Sheth will step down as Chairman, effective November 09, 2025, due to age-related reasons. Bharat K. Sheth, currently Deputy Chairman and Managing Director, will assume the role of Chairman. The Board has named K.M. Sheth as ‘Chairman Emeritus’ in recognition of his service. These changes reflect a strategic transition in leadership for the company.

Leadership Transition at Great Eastern Shipping

Effective November 09, 2025, K.M. Sheth will step down from his position as the Non-Executive Chairman of Great Eastern Shipping due to age-related reasons. He joined the company in 1952 and has been a pivotal figure in its growth.

Appointment of Bharat K. Sheth

The Board of Directors has appointed Bharat K. Sheth, currently the Deputy Chairman and Managing Director, as the new Chairman of the company, also effective November 09, 2025. He will now be designated as ‘Chairman and Managing Director’. He joined the company in 1981.

Recognition of K.M. Sheth’s Contribution

In recognition of his long and distinguished service, the Board has appointed K.M. Sheth as ‘Chairman Emeritus’ of the Company for life. This position is honorary.

Source: BSE

Max Healthcare Amalgamation Scheme Approved for Crosslay and Jaypee Healthcare

0

Max Healthcare Institute Limited announces that the Scheme of Amalgamation between Crosslay Remedies Limited and Jaypee Healthcare Limited has been officially sanctioned. The National Company Law Tribunal approved the merger, effective October 5, 2024. This strategic move consolidates Max Healthcare’s subsidiary operations, streamlining the group structure. The approval was granted on November 7, 2025.

Merger Sanctioned by Tribunal

The National Company Law Tribunal has officially approved the Scheme of Amalgamation involving Crosslay Remedies Limited and Jaypee Healthcare Limited, both wholly-owned subsidiaries of Max Healthcare Institute Limited. The order, received on November 7, 2025, signifies a key milestone in the company’s restructuring efforts.

Effective Date and Operational Changes

The appointed date for the amalgamation is set for October 5, 2024, as outlined in the approved scheme. With the sanction, Crosslay Remedies Limited will be dissolved without winding up, and its assets and liabilities will be integrated into Jaypee Healthcare Limited. All related contracts and employee agreements will transfer to Jaypee Healthcare, maintaining existing terms.

Scheme Details

The amalgamation scheme ensures the continuation of all legal and taxation proceedings. Further, the authorized share capital will also be adjusted. This merger streamlines the operations of Max Healthcare and is expected to bring efficiency to the overall organizational structure. With effect from the Effective Date, the Authorised Share Capital of the Company is INR 7,57,00,00,000.

Source: BSE